Hurricane Capital Advisors’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
Other funds holding DMAC
Hurricane Capital Advisors's DMAC Position: Q3 2026 in Review
Hurricane Capital Advisors increased its DiaMedica Therapeutics (DMAC) stake by 65% in Q3 2026, buying an estimated $308K and bringing the position to 111,582 shares worth $923K. The position accounts for 0.08% of the portfolio, ranked #164.
Hurricane Capital Advisors first reported a position in DMAC in Q1 2026 and has held it in 3 quarters since. 96 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.
- Hurricane Capital Advisors held 111,582 shares of DiaMedica Therapeutics worth $923K as of Q3 2026.
- Hurricane Capital Advisors bought 44,110 DiaMedica Therapeutics shares in Q3 2026, an estimated $308K.
- DiaMedica Therapeutics made up 0.08% of Hurricane Capital Advisors's portfolio in Q3 2026, its #164 holding.
- Hurricane Capital Advisors first reported a position in DiaMedica Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 96 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.
Based on Hurricane Capital Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.